- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/4045 - Indole-alkylaminesAmides thereof, e.g. serotonin, melatonin
Patent holdings for IPC class A61K 31/4045
Total number of patents in this class: 2933
10-year publication summary
|
166
|
161
|
154
|
179
|
244
|
346
|
389
|
320
|
338
|
179
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Caamtech, Inc. | 151 |
81 |
| GH Research Ireland Limited | 90 |
77 |
| Psilo Scientific Ltd. | 54 |
41 |
| Cybin IRL Limited | 71 |
40 |
| Cybin UK Ltd | 44 |
30 |
| Turtle Bear Holdings, LLC | 91 |
28 |
| Enveric Biosciences Canada Inc. | 65 |
28 |
| Atai Therapeutics, Inc. | 92 |
26 |
| Société des Produits Nestlé S.A. | 10040 |
25 |
| Mindset Pharma Inc. | 67 |
24 |
| Hisamitsu Pharmaceutical Co., Inc. | 776 |
22 |
| Terran Biosciences, Inc. | 109 |
22 |
| Beckley Psytech Limited | 46 |
20 |
| H. Lundbeck A/S | 1242 |
18 |
| Novartis AG | 10174 |
17 |
| Compass Pathfinder Limited | 122 |
17 |
| The Regents of the University of California | 20868 |
15 |
| Inserm (institut National de La Sante et de La Recherche Medicale) | 3325 |
14 |
| Gilgamesh Pharmaceuticals, Inc. | 66 |
14 |
| Eleusis Therapeutics US, Inc. | 25 |
14 |
| Other owners | 2360 |